Akoya Biosciences, Inc.
AKYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $113,168 | $216,841 | $361,238 | $572,963 |
| - Cash | $11,779 | $83,125 | $74,229 | $113,079 |
| + Debt | $84,146 | $85,706 | $75,784 | $32,940 |
| Enterprise Value | $185,535 | $219,422 | $362,793 | $492,824 |
| Revenue | $81,672 | $96,633 | $74,859 | $54,917 |
| % Growth | -15.5% | 29.1% | 36.3% | – |
| Gross Profit | $47,878 | $56,305 | $43,390 | $34,218 |
| % Margin | 58.6% | 58.3% | 58% | 62.3% |
| EBITDA | -$37,136 | -$45,632 | -$58,815 | -$35,168 |
| % Margin | -45.5% | -47.2% | -78.6% | -64% |
| Net Income | -$55,365 | -$63,323 | -$70,641 | -$42,935 |
| % Margin | -67.8% | -65.5% | -94.4% | -78.2% |
| EPS Diluted | -1.12 | -1.43 | -1.87 | -1.19 |
| % Growth | 21.7% | 23.5% | -57.1% | – |
| Operating Cash Flow | -$44,103 | -$50,899 | -$53,496 | -$36,068 |
| Capital Expenditures | -$2,456 | -$3,653 | -$7,360 | -$5,094 |
| Free Cash Flow | -$46,559 | -$54,552 | -$60,856 | -$41,162 |